Seitz M
Department of Rheumatology, University Hospital, Inselspital, Berne, Switzerland.
Curr Opin Rheumatol. 1999 May;11(3):226-32. doi: 10.1097/00002281-199905000-00012.
In 1998, knowledge about the mechanisms of action of methotrexate (MTX) in immunoinflammatory disorders further increased. The most interesting results to date came from studies showing that most of the anti-inflammatory actions of MTX are mediated by adenosine, which may account for the profound effects of MTX on cytokines, cytokine inhibitors, and cell differentiation. Finally, potential novel pharmacologic strategies are discussed based on actual knowledge about the molecular and cellular actions of MTX.
1998年,关于甲氨蝶呤(MTX)在免疫炎症性疾病中的作用机制的知识进一步增加。迄今为止,最有趣的结果来自于研究表明,MTX的大多数抗炎作用是由腺苷介导的,这可能解释了MTX对细胞因子、细胞因子抑制剂和细胞分化的深远影响。最后,基于对MTX分子和细胞作用的实际了解,讨论了潜在的新型药理学策略。